Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

(4S,6R)-Dorzolamide EP Impurity B

(4S,6R)-Dorzolamide EP Impurity B is listed in the pharmaceutical impurity collection under CAS 139066-77-6. Its represented structure has formula C10H16N2O4S3 and a calculated molecular weight of 324.45 g/mol.

2D chemical structure

N H S O O S S N H 2 O O ( S ) ( S )

Chemical identity

Catalog name
(4S,6R)-Dorzolamide EP Impurity B
Common name
(4S,6R)-Dorzolamide EP Impurity B
Chemical name
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide
CAS
139066-77-6
SMILES
CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21
InChI
InChI=1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1
InChIKey
IAVUPMFITXYVAF-XPUUQOCRSA-N
Associated API
(4S,6R)-Dorzolamide

Record ID: Afb40a8b7397e

Computed properties

C10H16N2O4S3 Molecular formula
324.449 g/molMolecular weight
324.0272 DaMonoisotopic exact mass
106.33 ŲTopological polar surface area
0.612 Calculated LogP (Wildman–Crippen)
73.3747 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O S 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight324.44951.51
Calculated LogP (Wildman–Crippen)0.61220.03
Topological polar surface area106.3375.38
Hydrogen-bond acceptors675.83
Hydrogen-bond donors264.87
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC10H16N2O4S3dimensionless
Molecular weight324.449g/mol
Monoisotopic exact mass324.0272Da
Topological polar surface area106.33Ų
Calculated LogP (Wildman–Crippen)0.612dimensionless
Molar refractivity (Wildman–Crippen)73.3747cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors2count
Rotatable bonds (strict)3count
Heavy atoms19count
Heteroatoms9count
Rings2count
Aromatic rings1count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.6fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area116.5315Ų
Valence electrons108count
Radical electrons0count
Bertz complexity690.357index
Balaban J2.6445index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for (4S,6R)-Dorzolamide EP Impurity B

Qualification and safety assessment of (4S,6R)-Dorzolamide EP Impurity B

Explore toxicological qualification of (4S,6R)-Dorzolamide EP Impurity B and ICH M7 mutagenic impurity assessment of (4S,6R)-Dorzolamide EP Impurity B for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for (4S,6R)-Dorzolamide EP Impurity B and acceptable intake and limit justification for (4S,6R)-Dorzolamide EP Impurity B. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for (4S,6R)-Dorzolamide EP Impurity B

Explore Altox services and software through the Altox Pharma-Hub.